There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Tandem Diabetes Care Inc. (TNDM) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.04, or -0.10%, to $41.96. The Tandem Diabetes Care Inc. has recorded 57,219 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook.
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $42.00 and fluctuated between $46.99 as its day high and $39.71 as its day low. The current market capitalization of Tandem Diabetes Care Inc. is $2.71B. A total of 2.66 million shares were traded on the day, compared to an average of 1.13M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, TNDM has seen 17 BUY and 14 SELL insider trades, representing the acquisition of 5,569 and the disposition of 2,030 shares. Over the last 12 months, there were 88 BUYs and 66 SELLs from insiders. Insiders purchased 86,548 shares during that period but sold 42,002.
In the most recent transaction, BERGER DAVID B sold 10,000 shares of TNDM for 40.25 per share on Dec 16. After the transaction, the EVP & Chief Operating Officer now owns 3,029 company shares. In a previous transaction on Dec 15, BERGER DAVID B sold 15,000 shares at 40.32 per share. TNDM shares that EVP & Chief Operating Officer owns now total 3,029.
Among the insiders who sold shares, BERGER DAVID B disposed of 10,097 shares on Jun 08 at a per-share price of $65.02. This resulted in the EVP & Chief Operating Officer holding 2,457 shares of TNDM after the transaction. In another insider transaction, BLICKENSTAFF KIM D sold 10,762 shares at $92.91 per share on May 17. Company shares held by the Director now total 205,190.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for TNDM in the last 3 months, the mean price target is $59.93 with high estimates of $80.00 and low estimates of $43.00. In terms of 52-week highs and lows, TNDM has a high of $132.18 and a low of $33.51.
As of this writing, TNDM has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $0.06 per share and a lower estimate of -$0.18. The company reported an EPS of -$0.23 in the last quarter, which was -228.60% lower than expectations of -$0.07.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 15 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TNDM is Underweight with a score of 4.22. A total of 8 analysts rated the stock as Buy while 3 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.